Objectives

After participating in this educational activity, attendees should be able to:

1. Describe the pathogenesis of sickle cell disease and identify associated complications and treatments
2. Describe the buprenorphine-naloxone microdose induction method and its use in patients with sickle cell disease
3. Evaluate data for alternative pain control methods (ketamine, crizanlizumab) in patients with sickle cell disease

Faculty

Katherine Marti, PharmD
PGY1 Pharmacy Resident
Pharmacist
Baystate Medical Center

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.